Amneal Pharmaceuticals is a global biopharmaceutical company with operations in the United States, India, and Ireland. Founded in 2002, it has grown into a major producer of complex generics, biosciences, and specialty medicines, with a portfolio of over 290 pharmaceutical products.
The company's technical work spans several demanding areas. Its biosimilars program develops lower-cost alternatives for cancer treatments, while its injectable medicines division addresses persistent drug shortages. These efforts reflect a core mission to make essential healthcare more accessible.
For professionals in AI and data roles, the breadth of Amneal's operations - across complex generics manufacturing, biosimilar development, and specialty medicine production - generates substantial data from research, clinical trials, supply chain logistics, and quality control systems. The company's focus on high-volume, complex pharmaceutical production presents a technical environment where data-driven approaches can have a significant impact.
